Joel Greenblatt's position in Charles River Laboratories International is currently worth $5.11 Million. That's 0.08% of their equity portfolio (350th largest holding). The first Charles River Laboratories International trade was made in Q1 2011. Since then Joel Greenblatt bought shares 23 more times and sold shares on 27 occasions. The stake costed the investor $4.98 Million, netting the investor a gain of 2.6% so far.